Cargando…
Inhibition of Notch signaling rescues cardiovascular development in Kabuki Syndrome
Kabuki Syndrome patients have a spectrum of congenital disorders, including congenital heart defects, the primary determinant of mortality. Seventy percent of Kabuki Syndrome patients have mutations in the histone methyl-transferase KMT2D. However, the underlying mechanisms that drive these congenit...
Autores principales: | Serrano, Maria de los Angeles, Demarest, Bradley L., Tone-Pah-Hote, Tarlynn, Tristani-Firouzi, Martin, Yost, H. Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743796/ https://www.ncbi.nlm.nih.gov/pubmed/31479440 http://dx.doi.org/10.1371/journal.pbio.3000087 |
Ejemplares similares
-
The commercialization of biospecimens from Indigenous Peoples: A scoping review of benefit-sharing
por: Tone-Pah-Hote, Tarlynn, et al.
Publicado: (2022) -
Small molecule inhibition of RAS/MAPK signaling ameliorates developmental pathologies of Kabuki Syndrome
por: Tsai, I-Chun, et al.
Publicado: (2018) -
Kabuki Syndrome with Cleft Palate
por: Paik, Joo Myong, et al.
Publicado: (2016) -
Kabuki syndrome and its anaesthetic management
por: Roy, Debashis, et al.
Publicado: (2011) -
Kabuki syndrome: clinical and molecular characteristics
por: Cheon, Chong-Kun, et al.
Publicado: (2015)